These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells. Li M, Li Z, Sun X. Eur J Pharmacol; 2008 Sep 04; 591(1-3):219-23. PubMed ID: 18619957 [Abstract] [Full Text] [Related]
7. RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension. Barman SA, Zhu S, White RE. Vasc Health Risk Manag; 2009 Sep 04; 5():663-71. PubMed ID: 19707285 [Abstract] [Full Text] [Related]
8. Treatment with platelet-derived growth factor (PDGF) and rock inhibitors is related to declined nerve growth factor (NGF) signaling in an experimental model of rat pulmonary hypertension. Jasińska-Stroschein M, Oszajca K, Świtlik W, Ruchwa J, Orszulak-Michalak D. Pharmacol Rep; 2017 Jun 04; 69(3):532-535. PubMed ID: 28363184 [Abstract] [Full Text] [Related]
18. Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone. Homma N, Nagaoka T, Karoor V, Imamura M, Taraseviciene-Stewart L, Walker LA, Fagan KA, McMurtry IF, Oka M. Am J Physiol Lung Cell Mol Physiol; 2008 Jul 04; 295(1):L71-8. PubMed ID: 18469113 [Abstract] [Full Text] [Related]
19. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats. Li FH, Xia W, Li AW, Zhao CF, Sun RP. Chin Med J (Engl); 2007 Jan 05; 120(1):22-9. PubMed ID: 17254483 [Abstract] [Full Text] [Related]